Economic implications of biological therapy for Crohn's disease

por Petryszyn, Paweł W., Paradowski, Leszek
Publicado 2015

Costs in inflammatory bowel diseases

por Petryszyn, Paweł W., Witczak, Izabela
Publicado 2016

Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients—A Systematic Review and Meta-Analysis

por Boszkiewicz, Kamila, Piwowar, Agnieszka, Petryszyn, Paweł
Publicado 2022

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland

por Petryszyn, Pawel, Ekk-Cierniakowski, Pawel, Zurakowski, Grzegorz
Publicado 2020

Non-medical costs of colonoscopy

por Petryszyn, Paweł W., Kempiński, Radosław, Michałowicz, Jerzy, Poniewierka, Elżbieta
Publicado 2014

Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis

por Petryszyn, Pawel, Niewinski, Piotr, Staniak, Aleksandra, Piotrowski, Patryk, Well, Anna, Well, Michal, Jeskowiak, Izabela, Lip, Gregory, Ponikowski, Piotr
Publicado 2019

C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case–Control and Meta-Analysis Study

por Petryszyn, Paweł, Dudkowiak, Robert, Gruca, Agnieszka, Jaźwińska-Tarnawska, Ewa, Ekk-Cierniakowski, Paweł, Poniewierka, Elżbieta, Wiela-Hojeńska, Anna, Głowacka, Krystyna
Publicado 2021